PubRank

Kwan Sik Lee

Author PubWeight™ 56.04‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 [Extrapancreatic tumors in intraductal papillary mucinous neoplasm of the pancreas]. Korean J Gastroenterol 2009 1.48
2 Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B. Gut 2013 1.46
3 Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis. Liver Int 2010 1.46
4 Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity. J Gastroenterol Hepatol 2004 1.39
5 Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2008 1.35
6 Twenty-four-week clevudine therapy showed potent and sustained antiviral activity in HBeAg-positive chronic hepatitis B. Hepatology 2007 1.33
7 Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int 2010 1.25
8 Clevudine is highly efficacious in hepatitis B e antigen-negative chronic hepatitis B with durable off-therapy viral suppression. Hepatology 2007 1.21
9 Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. Yonsei Med J 2005 1.17
10 A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010 1.15
11 Long-term outcome of chronic hepatitis B based on histological grade and stage. J Gastroenterol Hepatol 2007 1.15
12 Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model. Am J Gastroenterol 2011 1.14
13 How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol 2010 1.12
14 Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B. Hepatology 2010 1.11
15 Transitional features of histologic type of non-alcoholic fatty liver disease in Korean young men. J Gastroenterol Hepatol 2012 1.07
16 Hepatic stellate cells primed with cytokines upregulate inflammation in response to peptidoglycan or lipoteichoic acid. Lab Invest 2006 1.04
17 PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection. Oncology 2007 1.04
18 Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea. J Med Virol 2006 1.03
19 Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. Antivir Ther 2011 1.02
20 CD11b(+) Gr1(+) bone marrow cells ameliorate liver fibrosis by producing interleukin-10 in mice. Hepatology 2012 1.01
21 Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Eur J Gastroenterol Hepatol 2007 0.99
22 [Management of Chronic Hepatitis B]. Korean J Hepatol 2007 0.99
23 Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma. Clin Cancer Res 2006 0.98
24 Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int 2005 0.97
25 Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study. Radiology 2003 0.97
26 Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol 2012 0.95
27 A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients. Liver Int 2010 0.94
28 Apoptosis of hepatic stellate cells in carbon tetrachloride induced acute liver injury of the rat: analysis of isolated hepatic stellate cells. J Hepatol 2003 0.94
29 Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant 2010 0.92
30 The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J Gastroenterol Hepatol 2011 0.92
31 Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir. Antivir Ther 2009 0.89
32 Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study. J Korean Med Sci 2010 0.87
33 The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B. Antivir Ther 2006 0.87
34 Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study. J Clin Gastroenterol 2013 0.86
35 High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice. Clin Mol Hepatol 2013 0.85
36 [A case of duodenal adenocarcinoma arising from the heterotopic pancreas]. Korean J Gastroenterol 2003 0.84
37 The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma. Liver Int 2012 0.84
38 Clevudine-induced viral response, associated with continued reduction of HBsAg titer, was durable after the withdrawal of therapy. J Gastroenterol 2010 0.84
39 Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study. J Gastroenterol Hepatol 2014 0.82
40 A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem Cell Biol 2007 0.82
41 External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients. Dig Dis Sci 2009 0.82
42 Treatment outcome of transcatheter arterial chemoinfusion according to anticancer agents and prognostic factors in patients with advanced hepatocellular carcinoma (TNM stage IVa). Yonsei Med J 2004 0.81
43 Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats. Exp Mol Med 2011 0.81
44 Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 2013 0.80
45 Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study. Clin Mol Hepatol 2013 0.79
46 [Usefulness of urinary trypsinogen-2 dipstick test for diagnosis of acute pancreatitis]. Korean J Gastroenterol 2004 0.78
47 Salvage chemotherapy with docetaxel and epirubicin for advanced/metastatic gastric cancer. Oncology 2008 0.78
48 Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. Intervirology 2008 0.78
49 [Clevudine therapy in patients with chronic hepatitis B]. Korean J Hepatol 2009 0.77
50 p53 and p21WAF1/CIP1 in hepatitis B virus related hepatocarcinogenesis. Hepatogastroenterology 2003 0.77
51 Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients. J Gastroenterol Hepatol 2014 0.77
52 Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats. Apoptosis 2013 0.76
53 A single adenovirus-mediated relaxin delivery attenuates established liver fibrosis in rats. J Gene Med 2016 0.76
54 [Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases]. Korean J Hepatol 2008 0.76
55 Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 2011 0.76
56 Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. J Transl Med 2014 0.75
57 Assessment of the efficacy of reducing peginterferon alpha-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C. Korean J Intern Med 2009 0.75
58 [Acute hepatitis A complicated with acute kidney injury]. Korean J Gastroenterol 2010 0.75
59 Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea. Yonsei Med J 2006 0.75
60 Pyloric Brunner's gland hamartoma. Gastrointest Endosc 2004 0.75
61 [Clinical features and prognostic factors of fulminant hepatic failure in Koreans]. Korean J Hepatol 2004 0.75
62 Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B. Dig Dis Sci 2009 0.75
63 Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus. J Gastroenterol Hepatol 2014 0.75
64 Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts. Digestion 2012 0.75
65 [Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report]. Korean J Gastroenterol 2009 0.75
66 Duodenal metastatic amelanotic melanoma. Gastrointest Endosc 2003 0.75
67 Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B. J Gastroenterol Hepatol 2014 0.75
68 Clinical characteristics of acute hepatitis A complicated by acute kidney injury. Scand J Infect Dis 2011 0.75
69 [Type of electric currents used for standard endoscopic sphincterotomy does not determine the type of complications]. Korean J Gastroenterol 2004 0.75
70 Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment. J Clin Gastroenterol 2017 0.75